INTEGRA LIFESCIENCES HOLDINGS CORP — Form 8-K
Filed October 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 48/100
What the filing says
Integra reported Q3 2026 revenues of $411.2M (+2.3% reported, +2.5% organic) and adjusted EPS of $0.59 vs. $0.54 prior year. A $7M flood at Cincinnati facility hurt results; Tissue Reconstruction declined 2.2%. Post-quarter (Oct 19, 2026), company completed $2.1B refinancing ($1.65B senior secured credit facility + $450M 9.5% notes due 2033), extending debt maturities and temporarily loosening leverage covenants to 4.25x during 2027. Net debt is $1.516B (3.8x leverage). FY 2026 guidance: $1.634–$1.654B revenue (–0.1% to +1.2% reported), $2.30–$2.40 adjusted EPS.
Why this rating
Refinancing is material for liquidity/covenant relief; modest growth and flood disruption temper outlook. Event moderately significant relative to ~$925M market cap but not trajectory-changing.
See more from October 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.